Eton O - Search Results

1

Phase II trial of imatinib mesylate in patients with metastatic melanoma.

Kim KB, Eton O, Davis DW, Frazier ML, McConkey DJ, Diwan AH, Papadopoulos NE, Bedikian AY, Camacho LH, Ross MI, Cormier JN, Gershenwald JE, Lee JE, Mansfield PF, Billings LA, Ng CS, Charnsangavej C, Bar-Eli M, Johnson MM, Murgo AJ, Prieto VG. Kim KB, et al. Among authors: eton o. Br J Cancer. 2008 Sep 2;99(5):734-40. doi: 10.1038/sj.bjc.6604482. Epub 2008 Aug 19. Br J Cancer. 2008. PMID: 18728664 Free PMC article. Clinical Trial.

2

Phase II trial of 9-nitrocamptothecin (RFS 2000) for patients with metastatic cutaneous or uveal melanoma.

Ellerhorst JA, Bedikian AY, Smith TM, Papadopoulos NE, Plager C, Eton O. Ellerhorst JA, et al. Among authors: eton o. Anticancer Drugs. 2002 Feb;13(2):169-72. doi: 10.1097/00001813-200202000-00009. Anticancer Drugs. 2002. PMID: 11901310 Clinical Trial.

3

Phase I trial of subcutaneous recombinant human interleukin-2 in patients with metastatic melanoma.

Eton O, Rosenblum MG, Legha SS, Zhang W, Jo East M, Bedikian A, Papadopoulos N, Buzaid A, Benjamin RS. Eton O, et al. Cancer. 2002 Jul 1;95(1):127-34. doi: 10.1002/cncr.10631. Cancer. 2002. PMID: 12115326 Free article. Clinical Trial.

4

Phase II evaluation of temozolomide in metastatic choroidal melanoma.

Bedikian AY, Papadopoulos N, Plager C, Eton O, Ring S. Bedikian AY, et al. Among authors: eton o. Melanoma Res. 2003 Jun;13(3):303-6. doi: 10.1097/00008390-200306000-00013. Melanoma Res. 2003. PMID: 12777987 Clinical Trial.

5

Biochemotherapy in patients with metastatic anorectal mucosal melanoma.

Kim KB, Sanguino AM, Hodges C, Papadopoulos NE, Eton O, Camacho LH, Broemeling LD, Johnson MM, Ballo MT, Ross MI, Gershenwald JE, Lee JE, Mansfield PF, Prieto VG, Bedikian AY. Kim KB, et al. Among authors: eton o. Cancer. 2004 Apr 1;100(7):1478-83. doi: 10.1002/cncr.20113. Cancer. 2004. PMID: 15042682 Free article.

6

Phase II evaluation of paclitaxel by short intravenous infusion in metastatic melanoma.

Bedikian AY, Plager C, Papadopoulos N, Eton O, Ellerhorst J, Smith T. Bedikian AY, et al. Among authors: eton o. Melanoma Res. 2004 Feb;14(1):63-6. doi: 10.1097/00008390-200402000-00010. Melanoma Res. 2004. PMID: 15091196 Clinical Trial.

7

Pilot study of high-dose, concurrent biochemotherapy for advanced melanoma.

Kim KB, Eton O, East MJ, Hodges C, Papadopoulos NE, Grimm EA, Bedikian AY. Kim KB, et al. Among authors: eton o. Cancer. 2004 Aug 1;101(3):596-603. doi: 10.1002/cncr.20403. Cancer. 2004. PMID: 15274073 Free article.

8

Multicenter Phase II trial of high-dose imatinib mesylate in metastatic melanoma: significant toxicity with no clinical efficacy.

Wyman K, Atkins MB, Prieto V, Eton O, McDermott DF, Hubbard F, Byrnes C, Sanders K, Sosman JA. Wyman K, et al. Among authors: eton o. Cancer. 2006 May 1;106(9):2005-11. doi: 10.1002/cncr.21834. Cancer. 2006. PMID: 16565971 Free article. Clinical Trial.

9

Analysis of protein tyrosine kinases expression in the melanoma metastases of patients treated with Imatinib Mesylate (STI571, Gleevec).

Ivan D, Niveiro M, Diwan AH, Eton O, Kim KB, Lacey C, Gonzalez C, Prieto VG. Ivan D, et al. Among authors: eton o. J Cutan Pathol. 2006 Apr;33(4):280-5. doi: 10.1111/j.0303-6987.2006.00432.x. J Cutan Pathol. 2006. PMID: 16630177

10

Changes in pERK1/2 and pAKT expression in melanoma lesions after imatinib treatment.

Hwang CS, Prieto VG, Diwan AH, Lizee G, Ellerhorst JA, Ekmekcioglu S, Liu P, Eton O, Kinney SA, Grimm EA, Hwu P, Kim KB. Hwang CS, et al. Among authors: eton o. Melanoma Res. 2008 Aug;18(4):241-5. doi: 10.1097/CMR.0b013e3283046146. Melanoma Res. 2008. PMID: 18626307 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

56 results

Search Page